Zhejiang Huahai Pharmaceutical Co., Ltd.

Operates across three lines: chemical and biological medicines, pharmaceutical packaging and trading. Its therapeutic focus is cardiovascular, central nervous system and antivirals. It states it was the first Chinese manufacturer with US FDA certification for finished product and with a generic approval there. It has over forty subsidiaries and sells in around two hundred countries. Founded in 1989.